Chromosomal aberrations in benign prostatic hyperplasia patients

Investig Clin Urol. 2016 Jan;57(1):45-9. doi: 10.4111/icu.2016.57.1.45. Epub 2016 Jan 11.

Abstract

Purpose: To investigate the chromosomal changes in patients with benign prostatic hyperplasia (BPH).

Materials and methods: A total of 54 patients diagnosed with clinical BPH underwent transurethral prostate resection to address their primary urological problem. All patients were evaluated by use of a comprehensive medical history and rectal digital examination. The preoperative evaluation also included serum prostate-specific antigen (PSA) measurement and ultrasonographic measurement of prostate volume. Prostate cancer was detected in one patient, who was then excluded from the study. We performed conventional cytogenetic analyses of short-term cultures of 53 peripheral blood samples obtained from the BPH patients.

Results: The mean (±standard deviation) age of the 53 patients was 67.8±9.4 years. The mean PSA value of the patients was 5.8±7.0 ng/mL. The mean prostate volume was 53.6±22.9 mL. Chromosomal abnormalities were noted in 5 of the 53 cases (9.4%). Loss of the Y chromosome was the most frequent chromosomal abnormality and was observed in three patients (5.7%). There was no statistically significant relationship among age, PSA, prostate volume, and chromosomal changes.

Conclusions: Loss of the Y chromosome was the main chromosomal abnormality found in our study. However, this coexistence did not reach a significant level. Our study concluded that loss of the Y chromosome cannot be considered relevant for the diagnosis of BPH as it is for prostate cancer. Because BPH usually occurs in aging men, loss of the Y chromosome in BPH patients may instead be related to the aging process.

Keywords: Chromosomes; Genes; Hyperplasia; Prostate.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Chromosome Aberrations*
  • Chromosomes, Human, Y / genetics
  • Genetic Predisposition to Disease
  • Humans
  • Karyotype
  • Male
  • Middle Aged
  • Prostate-Specific Antigen / blood
  • Prostatic Hyperplasia / genetics*
  • Prostatic Hyperplasia / pathology
  • Prostatic Hyperplasia / surgery
  • Transurethral Resection of Prostate

Substances

  • Prostate-Specific Antigen